Interactive Cardiovascular and Thoracic Surgery 2:424-426(2003)
© 2003 European Association of Cardio-Thoracic Surgery
Best evidence topic - Cardiac general |
In patients post cardiac surgery do high doses of protamine cause increased bleeding?
Kenneth Edward Mclaughlina and
Joel Dunningb,*
a Department of Cardiothoracic Surgery, Wythenshawe, South Moor Road, Manchester, M23 9LT, UK
b Department of Cardiothoracic Surgery, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK
* Corresponding author. Tel.: +44-7801548122 joeldunning{at}doctors.org.uk
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether high doses of protamine causes increased bleeding in patients post cardiac surgery. Altogether 268 papers were found using the reported search, of which five presented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of these papers are tabulated. We conclude that high doses of protamine can cause increased bleeding and impaired platelet function but these effects have never been demonstrated below a ratio of 2.6:1 protamine to heparin.
Key Words: Evidence-based medicine; Thoracic surgery; Protamines; Haemorrhage
This article has been cited by other articles:

|
 |

|
 |
 
F. Ni Ainle, R. J. S. Preston, P. V. Jenkins, H. J. Nel, J. A. Johnson, O. P. Smith, B. White, P. G. Fallon, and J. S. O'Donnell
Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation
Blood,
August 20, 2009;
114(8):
1658 - 1665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. G. Nielsen
Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation.
Ann. Thorac. Surg.,
May 1, 2006;
81(5):
1720 - 1727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Smythe, W. E. Dager, and N. M. Patel
Managing Complications of Anticoagulant Therapy
Journal of Pharmacy Practice,
October 1, 2004;
17(5):
327 - 346.
[Abstract]
[PDF]
|
 |
|
|
|